Extensive Product Profile: Understanding Doripenem for Injection 250 mg Doripenem for Injection 250 mg is a highly potent, broad-spectrum carbapenem antibiotic. It is a synthetic beta-lactam agent characterized by its robust stability against various beta-lactamases and its ability to maintain efficacy against many gram-positive and gram-negative pathogens, including those resistant to other standard therapies. 1. Clinical Indications & Usage Doripenem is primarily reserved for the management of severe bacterial infections in a clinical or hospital setting. Its clinical indications include: Complicated Intra-Abdominal Infections: Used in the treatment of complicated appendicitis and peritonitis, often requiring surgical intervention alongside antibiotic therapy. Complicated Urinary Tract Infections (cUTIs): Indicated for serious infections such as pyelonephritis and infections complicated by systemic bacteremia. Severe Respiratory Infections: Utilized in the management of specific nosocomial (hospital-acquired) pneumonia cases where pathogens may exhibit multi-drug resistance. 2. Mechanism of Action Doripenem exerts its bactericidal activity through a highly effective multi-step molecular mechanism: Inhibition of Cell Wall Synthesis: Doripenem possesses a high affinity for essential penicillin-binding proteins (PBPs), specifically PBP 2, 3, and 4 in Pseudomonas aeruginosa and other gram-negative bacteria. Structural Stability: Unlike many other beta-lactam antibiotics, doripenem exhibits significant stability against hydrolysis by most beta-lactamases, including penicillinases and cephalosporinases, which prevents bacteria from neutralizing the drug. Bactericidal Outcome: By effectively disrupting the cross-linking of peptidoglycan chains within the bacterial cell wall, the drug induces rapid cell lysis and death, effectively halting the infection. 3. Administration and Dosing Administration Route: Doripenem 250 mg is formulated as a sterile powder for reconstitution and is administered strictly via intravenous (IV) infusion. Preparation: The powder must be reconstituted using compatible intravenous diluents (such as Sterile Water for Injection or 0.9% Sodium Chloride). Once reconstituted, the solution should be diluted further before infusion. Dosing Guidelines: Dosing is strictly tailored by a medical professional based on the specific infection type, the patient’s creatinine clearance (renal function), and the severity of the clinical presentation. It is typically administered every 8 hours. ⚠️ Safety, Side Effects, and Monitoring Hypersensitivity: Contraindicated in patients with a history of severe hypersensitivity to any drug in the carbapenem class or those with a history of anaphylaxis to any beta-lactam antibiotic. Central Nervous System (CNS) Risks: Carbapenems, including doripenem, have been associated with a risk of seizures. Use with caution in patients with underlying CNS disorders or compromised renal function. Common Side Effects: Observed clinical side effects include headache, nausea, diarrhea, rash, and phlebitis at the intravenous site. Monitoring: Clinicians must monitor for superinfections, particularly Clostridioides difficile-associated diarrhea, and conduct regular assessments of renal function throughout the treatment duration. 📦 Storage and Handling Storage Framework: Keep the unopened vials stored at controlled room temperature (20°C to 25°C). Ensure the environment is dry and protected from direct light. Stability: The reconstituted and diluted solution should be used according to validated clinical stability protocols to ensure the medication remains sterile and active. PRESCRIPTION MEDICINE IS : YES Clinical Disclaimer: This profile is compiled for medical professional information and clinical research. Doripenem for Injection 250 mg is a prescription-only medication and must be administered strictly under the supervision of a licensed physician or within a controlled hospital environment. It is not indicated for use in pediatric populations and should only be used during pregnancy when the clear clinical benefit to the mother outweighs the potential risk to the fetus. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383